Lundbeck
HLUN-B.CO
#2346
Rank
NZ$10.56 B
Marketcap
$10.92
Share price
0.98%
Change (1 day)
20.87%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$3.69 B

According to Lundbeck 's latest financial reports the company's total liabilities are NZ$3.69 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lundbeck - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$3.59 B-4.87%
2022-12-31NZ$3.78 B3.89%
2021-12-31NZ$3.64 B-16.89%
2020-12-31NZ$4.37 B-7.71%
2019-12-31NZ$4.74 B137.29%
2018-12-31NZ$1.99 B16.31%
2017-12-31NZ$1.71 B-20.01%
2016-12-31NZ$2.14 B-20.04%
2015-12-31NZ$2.68 B6.6%
2014-12-31NZ$2.52 B10.01%
2013-12-31NZ$2.29 B26.7%
2012-12-31NZ$1.80 B4.48%
2011-12-31NZ$1.73 B8.33%
2010-12-31NZ$1.59 B-28.12%
2009-12-31NZ$2.22 B36.24%
2008-12-31NZ$1.63 B25.37%
2007-12-31NZ$1.30 B6.31%
2006-12-31NZ$1.22 B27.82%
2005-12-31NZ$0.95 B2.34%
2004-12-31NZ$0.93 B